22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands
November 16, 2022 09:25 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 16, 2022 (GLOBE NEWSWIRE) -- GVB Biopharma, a 22nd Century Group company (Nasdaq: XXII), today announced that it has opened a new, strategically-located distribution facility in...
22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas
November 15, 2022 09:25 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 15, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences
November 14, 2022 08:19 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022
November 08, 2022 06:00 ET
|
22nd Century Group, Inc
Accelerating VLN® Sales in Colorado and Illinois, Launching in Four Corners States to Capture Market Share and VolumeGVB Biopharma Acquisition Growing Revenue on Increased VolumesThird Quarter Net...
New Study Again Shows 22nd Century’s Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation
November 07, 2022 09:43 ET
|
22nd Century Group, Inc
Reduced nicotine cigarettes increase cessation, decrease consumption, decrease dependence, and reduce toxicantsStudy dispels common misconception that reduced nicotine cigarettes worsen general health...
22nd Century Group (Nasdaq: XXII) to Announce Third Quarter 2022 Results on November 8, 2022
October 27, 2022 09:15 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Oct. 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group (Nasdaq: XXII) to Expand VLN® Sales in Three Additional States: Arizona, Utah and New Mexico
October 26, 2022 09:25 ET
|
22nd Century Group, Inc
Combined with Ongoing Launch in Colorado, VLN® Will Be Available in All “Four Corners” StatesUtah and New Mexico Join Colorado as VLN® States with Favorable MRTP Excise Tax Programs BUFFALO, N.Y.,...
22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26
October 18, 2022 09:20 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Oct. 18, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group (Nasdaq: XXII) to Participate in the Dawson James Small Cap Growth Conference on October 12
October 06, 2022 16:05 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Oct. 06, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
First Cigarette Authorized by FDA to “Help You Smoke Less” Now Available Across Colorado
October 06, 2022 09:30 ET
|
22nd Century Group, Inc
VLN® cigarettes from 22nd Century Group contain 95% less nicotine than conventional cigarettes, greatly reducing nicotine consumption to help smokers smoke less; support State and FDA goals of...